Back to search
Malignant Neoplasm of Prostate
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Neoplasm of Prostate trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Neoplasm of Prostate trials you may qualify forThe purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with me…
The goal of this clinical trial is to learn if a low to moderate load power training program is feasible and effective for improving fitness and quality of life…
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants fo…
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors th…
This is a multi-center, open-label Phase 1/2 trial evaluating the safety and efficacy of AB-3028 in subjects with metastatic castration resistant prostate cance…
This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have i…
This phase I/II trial studies the side effects of avelumab when given in different combinations with utomilumab, anti-OX40 antibody PF-04518600, and radiation t…